胰腺癌免疫治疗研究进展及临床应用前景探讨

Research Progress and Clinical Application Prospect of Immunotherapy for Pancreatic Cancer

摘要: 随着科学技术的进步，胰腺癌作为一种高度致命性肿瘤，其治疗策略不断革新。本综述分析了胰腺癌的手术治疗、影像学诊断、免疫治疗以及相关生物标志物的研究进展，并讨论了肿瘤治疗副作用和对策，以及其他癌症的相关研究。特别关注了胰腺癌在免疫治疗方面的最新动态，包括胰腺癌腹水模型的建立，抗IL-9抗体治疗的前景，以及直接靶向PD-1的治疗方法。同时，也着眼于通过整合生物信息学分析来揭示胰腺癌分子过程的异常和信号通路的失调。此外，综述凸显了研究方法和医学文献翻译在当前课题中的重要性。通过阐述各研究领域内的先进成果和现存的挑战，为胰腺癌免疫治疗的临床应用前景提供了一定的参考。

Abstract: With the advancement of science and technology, pancreatic cancer, a highly lethal tumor, has experienced revolutionary treatment strategies. This review analyzes the progress in surgical treatment, radiological diagnosis, immunotherapy, and related biomarkers for pancreatic cancer, and discusses the side effects of tumor treatment and strategies to mitigate them, along with relevant research on other cancers. The review particularly focuses on the latest developments in immunotherapy for pancreatic cancer, including the establishment of a pancreatic cancer ascites mouse model, the prospective role of anti-IL-9 antibody therapy, and direct targeting of the PD-1 immune checkpoint. Additionally, it highlights the relevance of integrative bioinformatics analyses for uncovering aberrations in molecular processes and signaling pathway dysregulation in pancreatic cancer. Moreover, the review underscores the significance of research methodologies and the translation of medical literature in this field. By articulating the pioneering findings and ongoing challenges within each domain, the review provides insights into the potential clinical application prospects for immunotherapy in pancreatic cancer.